InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Harris Matthew Scott, Directeur Médical. Officer active across 1 company, notably Altimmune, Inc.. Aggregated, 16 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €39k. History available since 31 July 2021. The latest transaction was filed on 31 July 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Harris Matthew Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
2,018 shares@ US$3.143.2% of flowCommon Stock, par value $0.0001SEC:0001104659-25-073627:0
67,787 shares0Common Stock, par value $0.0001SEC:0001104659-25-022550:0
9,275 shares0Common Stock, par value $0.0001SEC:0001104659-25-008772:0
4,994 shares@ US$6.9818.2% of flowCommon Stock, par value $0.0001SEC:0001104659-25-006841:1
14,600 shares0Common Stock, par value $0.0001SEC:0001104659-25-006841:0
1,486 shares@ US$5.414.0% of flowCommon Stock, par value $0.0001SEC:0001104659-24-084991:0
6,166 shares0Common Stock, par value $0.0001SEC:0001104659-24-010779:0
9,275 shares0Common Stock, par value $0.0001SEC:0001104659-24-009540:0
691 shares@ US$2.811.0% of flowCommon Stock, par value $0.0001SEC:0001104659-23-086905:0
10,000 shares@ US$4.2221.1% of flowCommon Stock, par value $0.0001SEC:0001104659-23-036172:0
Canonical exit: 21 Jun 2023 (T+90)
7,775 shares0Common Stock, par value $0.0001SEC:0001104659-23-011211:0
1,296 shares@ US$10.20856.6% of flowCommon Stock, par value $0.0001SEC:0001104659-23-009974:0
1,076 shares@ US$6.863.9% of flowCommon Stock, par value $0.0001SEC:0001104659-22-085624:0
30,000 shares@ US$1.921329.7% of flowCommon Stock, par value $0.0001SEC:0001104659-22-029462:0
1,800 shares@ US$6.866.4% of flowCommon Stock, par value $0.0001SEC:0001104659-22-011519:0
725 shares@ US$7.70952.7% of flowCommon Stock, par value $0.0001SEC:0001104659-21-101663:0
16 of 16 declarations
About Harris Matthew Scott
Harris Matthew Scott is Chief Medical Officer at Altimmune, Inc. (XNAS). He has 16 filings in total, and across the sampled recent filings, buys total 38821 EUR and sells total 0 EUR, over the period from 2021-08-06 to 2025-08-04, with the modal transaction nature stated as Attribution.
